Philip Morris is shaping the debate with “Technovation.”
Philip Morris International (PMI) presents itself as a technology company working toward a “smoke-free future,” with products such as IQOS, ILUMA, and ZYN as supposedly less harmful alternatives to cigarettes. Through international “Technovation” symposia, the company influences journalists, scientists, politicians, and policymakers under the guise of science, innovation, and harm reduction.
Research into media coverage of the symposia reveals the extent of this influence: 80 to 95 percent of the argumentative structure and 70 to 90 percent of the vocabulary used in news reports corresponded to PMI’s own texts. Through massive repetition, search engine optimization, and media attention, the appearance of broad, independent support is created, even though the messages largely originate from the same industrial source. AI amplifies this effect, as frequently repeated industry messages also appear in search results and AI responses.
The result: misinformation about harm reduction gains scientific credibility and influences both public opinion and regulation. In essence, PMI is thus not only trying to sell nicotine products but also to dominate the information landscape: by repeating its own narrative, marketing is increasingly presented as independent science.
